{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:14:48Z","timestamp":1793060088774,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi and Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijantimicag.2025.107465","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:12:23Z","timestamp":1739819543000},"page":"107465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cefiderocol pharmacokinetics in critically-ill patients receiving extra-corporeal membrane oxygenation (ECMO)"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-3496","authenticated-orcid":false,"given":"Christina","family":"Koenig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Fratoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Abouelhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Gluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4464-3126","authenticated-orcid":false,"given":"Joseph L.","family":"Kuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107465_bib0001","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MAT.0000000000001344","article-title":"Extracorporeal cardiopulmonary resuscitation in adults. Interim guideline consensus statement from the Extracorporeal Life Support Organization","volume":"67","author":"Richardson","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0002","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MAT.0000000000001432","article-title":"Management of adult patients supported with venovenous Extracorporeal membrane oxygenation (VV ECMO): guideline from the Extracorporeal Life Support Organization (ELSO)","volume":"67","author":"Tonna","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0003","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/PCC.0b013e3181e28894","article-title":"Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults","volume":"12","author":"Bizzarro","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MAT.0000000000002128","article-title":"Extracorporeal Life Support Organization Registry International Report 2022: 100,000 survivors","volume":"70","author":"Tonna","year":"2024","journal-title":"ASAIO J"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijantimicag.2014.11.005","article-title":"\u03b2-lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: a case\u2013control study","volume":"45","author":"Donadello","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/17425255.2019.1563596","article-title":"Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients","volume":"15","author":"Cheng","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.hjc.2022.07.003","article-title":"Interaction between veno-arterial extracorporeal membrane oxygenation and the right ventricle","volume":"68","author":"Puerto","year":"2022","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0008","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-015-0891-z","article-title":"Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study","volume":"19","author":"Shekar","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0009","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/cc11679","article-title":"Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation","volume":"16","author":"Shekar","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13054-024-04946-8","article-title":"Incidence, risk factors and outcomes of nosocomial infection in adult patients supported by extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"28","author":"Ait Hssain","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0011","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0012","doi-asserted-by":"crossref","first-page":"S552","DOI":"10.1093\/cid\/ciz828","article-title":"Pharmacokinetic and pharmacodynamic profiles of cefiderocol, a novel siderophore cephalosporin","volume":"69","author":"Katsube","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0013","article-title":"PubChem compound summary for CID 77843966","volume":"2024","year":"2024","journal-title":"Cefiderocol"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0014","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s13318-023-00840-w","article-title":"Cefiderocol is not sequestered in an ex vivo extracorporeal membrane oxygenation (ECMO) circuit","volume":"48","author":"Berry","year":"2023","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/antibiotics13040373","article-title":"No sequestration of commonly used anti-infectives in the extracorporeal membrane oxygenation (ECMO) circuit-an ex vivo study","volume":"13","author":"Booke","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0016","series-title":"Fetroja (cefiderocol) package insert","year":"2020"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0017","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R","volume":"34","author":"Neely","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01437-20","article-title":"Population pharmacokinetic and pharmacokinetic\/pharmacodynamic analyses of cefiderocol, a parenteral siderophore cephalosporin, in patients with pneumonia, bloodstream infection\/sepsis, or complicated urinary tract infection","volume":"65","author":"Kawaguchi","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13054-024-04911-5","article-title":"Impact of attaining aggressive vs. conservative PK\/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis","volume":"28","author":"Gatti","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0021","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00134-022-06847-2","article-title":"Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software","volume":"48","author":"Roberts","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0022","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.3390\/jcm11236898","volume":"11","author":"Bakdach","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106466","article-title":"Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study)","volume":"58","author":"Cheng","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9112219","article-title":"Prediction of insufficient beta-lactam concentrations in extracorporeal membranous oxygenation patients","volume":"9","author":"Polain","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/PCC.0000000000002174","article-title":"Oxygenator impact on ceftolozane and tazobactam in extracorporeal membrane oxygenation circuits","volume":"21","author":"Cies","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0026","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12967-020-02381-1","article-title":"Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane\/tazobactam: an ex vivo and in vivo study","volume":"18","author":"Man\u00e9","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0027","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/pharmaceutics14122786","article-title":"Total and unbound pharmacokinetics of cefiderocol in critically ill patients","volume":"14","author":"Zahr","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0028","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jcph.841","article-title":"Cefiderocol, a siderophore cephalosporin for Gram-negative bacterial infections: pharmacokinetics and safety in subjects with renal impairment","volume":"57","author":"Katsube","year":"2017","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2369-14-250","article-title":"A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations","volume":"14","author":"Udy","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijantimicag.2017.10.008","article-title":"Pharmacodynamics of cefiderocol, a novel siderophore cephalosporin, in a Pseudomonas aeruginosa neutropenic murine thigh model","volume":"51","author":"Ghazi","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0031","doi-asserted-by":"crossref","first-page":"e02031","DOI":"10.1128\/AAC.02031-18","article-title":"In vivo pharmacodynamic study of cefiderocol, a novel parenteral siderophore cephalosporin, in murine thigh and lung infection models","volume":"63","author":"Nakamura","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0032","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jgar.2021.10.014","volume":"27","author":"Gatti","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0033","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/antibiotics10060649","article-title":"Cefiderocol in critically ill patients with multi-drug resistant pathogens: real-life data on pharmacokinetics and microbiological surveillance","volume":"10","author":"K\u00f6nig","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0034","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/02676591231160462","article-title":"Pharmacokinetics of cefiderocol during extracorporeal membrane oxygenation: a case report","volume":"38","author":"Riera","year":"2023","journal-title":"Perfusion"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00134-014-3641-9","article-title":"Comparison of different equations to assess glomerular filtration in critically ill patients","volume":"41","author":"Carlier","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00309-23","article-title":"Cefepime population pharmacokinetics, antibacterial target attainment, and estimated probability of neurotoxicity in critically ill patients","volume":"67","author":"Bilal","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0037","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/1049909110384841","article-title":"Hypoalbuminemia in critically ill patients with cancer: incidence and mortality","volume":"28","author":"\u00d1amendys-Silva","year":"2011","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0038","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MAT.0000000000000984","article-title":"Prognostic factors for survival after extracorporeal membrane oxygenation for cardiogenic shock","volume":"66","author":"Huang","year":"2020","journal-title":"Asaio J"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105983","article-title":"Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: a prospective, observational, cohort study","volume":"9","author":"Jellinge","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5090\/jcs.22.130","article-title":"Hypoalbuminemia and albumin replacement during extracorporeal membrane oxygenation in patients with cardiogenic shock","volume":"56","author":"Jeon","year":"2023","journal-title":"J Chest Surg"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0041","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1093\/jac\/dkab314","article-title":"High unbound flucloxacillin fraction in critically ill patients","volume":"76","author":"Wallenburg","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0042","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12028-018-0627-4","article-title":"Accuracy of valproic acid concentration correction based on serum albumin","volume":"30","author":"Drisaldi","year":"2019","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0043","doi-asserted-by":"crossref","first-page":"e02466","DOI":"10.1128\/AAC.02466-18","article-title":"Pharmacokinetics of Caspofungin in critically ill patients in relation to liver dysfunction: differential impact of plasma albumin and bilirubin levels","volume":"63","author":"Kurland","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107465_bib0044","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jac\/dkae079","article-title":"Imipenem\/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation","volume":"79","author":"Fratoni","year":"2024","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:42:43Z","timestamp":1762321363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0924857925000238"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107465","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefiderocol pharmacokinetics in critically-ill patients receiving extra-corporeal membrane oxygenation (ECMO)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107465"}}